genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Teva
Drug Discovery
FDA Approves Teva’s AUSTEDO for Treating Huntington’s Disease
Drug Discovery
Teva to Shrink Workforce; Denies Up to 6,000 Jobs Will Go
Industry News
Teva Names Interim CEO as Vigodman Steps Down
A-Lists
Top 10 M&A Deals of 2016
A-Lists
Top 10 Molecular Millionaires
Industry News
Teva, IBM Plan Drug Repurposing, Chronic Disease Management Efforts
Drug Discovery
Teva Partners with Regeneron to Develop Pain Candidate Fasinumab
Drug Discovery
After Completing $39B Acquisition, Teva Does Another Generics Deal with Allergan
Industry News
Impax Buys Generic Product Portfolio from Teva, Allergan for $586M
Drug Discovery
Sagent Buys Five ANDAs, Including Propofol, from Teva for $40M
1
2
3
...
11
Page 2 of 11
Scroll Up
Scroll Up
